Syncona Share News (SYNC)

Syncona Net Asset Value Climbs Amid Burgeoning Life Sciences Portfolio

LONDON (Alliance News) - Healthcare investor Syncona Ltd said Thursday its net assets increased significantly in its financial first quarter, due to the strong performance and increasing size of a

Syncona Invests GBP85 Million Into Freeline During Funding Round

LONDON (Alliance News) - FTSE 250-listed healthcare investment company Syncona Ltd said on Tuesday it has invested GBP85 million in Adeno-associated virus gene therapy company virus is a small and

Syncona Report 18% Growth In Net Assets As Portfolio Firms Prosper

LONDON (Alliance News) - Syncona Ltd on Thursday said strong results from its science portfolio and new investments resulted in an increased return for the 2018 financial year.The FTSE life

CORRECT (June 8): Syncona, Woodford And Arix Investee Plans ADS Offer

(Correcting Syncona and Woodford's shareholding value in Autolus Therapeutics following the ADS offering)LONDON (Alliance News) - Healthcare investor Syncona Ltd said Friday that its an

Syncona Investee Autolus Therapeutics Planning Nasdaq Listing (ALLIPO)

LONDON (Alliance News) - Healthcare investor Syncona Ltd on Tuesday noted the proposed listing of American depositary shares on the Nasdaq Global Market by investee Autolus Therapeutics said the

Syncona's Blue Earth Signs Licence For Prostate Cancer Imaging Agent

LONDON (Alliance News) - Life science focused investment trust Syncona Ltd said Wednesday its portfolio company Blue Earth Diagnostics has signed an exclusive licence for a radio-hybride prostate

Syncona's Nightstar 2017 Loss Widens On Research And Development Costs

LONDON (Alliance News) - Healthcare-focused investment company Syncona Ltd said on Wednesday that itsportfolio company Nightstar Therapeutics PLC reported a widened loss in as

Syncona Revises Investment Management Arrangement To Save Costs

LONDON (Alliance News) - Syncona Ltd said on Tuesday it has revised its investment management agreement with BACIT UK Ltd in order to reduce costs for has

WINNERS & LOSERS SUMMARY: Investors Lose Appetite For Just Eat

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Smurfit up it

Syncona And Arix Bioscience Notes Potential US IPO For Autolus (ALLIPO)

LONDON (Alliance News) - FTSE 250-listed healthcare investment company Syncona Ltd said on Tuesday its portfolio company Autolus Ltd, has filed a confidential submission of a

Syncona's Nightstar Begins NSR-REP1 Trial And Appoints New Director

LONDON (Alliance News) - Healthcare-focused investment company Syncona Ltd said on Monday that portfolio company Nightstar Therapeutics PLC has initiated a STAR Phase Three to

Syncona Takes Advice On FCA's Pooled Investment Marketing Restrictions

Small caps round-up: Imaginatik, Braveheart, Healthcare Locums...

Imaginatik has signed a new annual contract with a leading provider of healthcare services and medical research in the US. The contract has an initial start-up phase worth $0.12m in the current calendar year, followed by an ongoing annual contract worth $0.15m a year, with Imaginatik supplying it

Wednesday newspaper round-up: Cove, Vodafone, HSBC

HSBC has admitted for the first time it may face criminal charges that could see it hit with "significant" penalties stemming from a US investigation into alleged money-laundering by Britain's biggest bank. The bank is being investigated over possible violations of the US Bank Secrecy Act. HSBC also

Friday newspaper round-up: Greece, Oil, BoE

Germany's ruling parties are to introduce a resolution in parliament blocking any further boost to the EU's bail-out machinery, vastly complicating Greece's rescue package and risking a major clash with the International Monetary Fund. European solidarity is not an end in itself and should not be a